XTL BIOPHARMACEUTICALS LTD. Adjustments For Increase Decrease In Trade Account Payable
XTL BIOPHARMACEUTICALS LTD. (XTLB) reported Adjustments For Increase Decrease In Trade Account Payable of $208.00 thousand for the 12-month period ending 2024-12-31, per its 20-F filed 2025-04-30.
Financial Statements › Notes
ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable · last filed 2025-04-30
| Period end | Adjustments For Increase Decrease In Trade Account Payable 6 month | Adjustments For Increase Decrease In Trade Account Payable 12 month | Adjustments For Increase Decrease In Trade Account Payable 12 month as first filed |
|---|---|---|---|
| 2024-12-31 | $208.00K 20-F · filed 2025-04-30 | ||
| 2023-12-31 | $19.00K 20-F · filed 2025-04-30 | ||
| 2022-12-31 | -$44.00K 20-F · filed 2025-04-30 | ||
| 2022-06-30 | -$59.00K 6-K · filed 2022-08-24 | ||
| 2021-12-31 | -$23.00K 20-F · filed 2023-03-22 | ||
| 2021-06-30 | $4.00K 6-K · filed 2022-08-24 | ||
| 2020-12-31 | $22.00K 20-F · filed 2023-03-22 | ||
| 2020-06-30 | -$38.00K 6-K · filed 2021-08-24 | ||
| 2019-12-31 | -$21.00K 20-F · filed 2022-03-30 | ||
| 2018-12-31 | -$47.00K 20-F/A · filed 2021-05-19 | ||
| 2017-12-31 | -$157.00K 20-F · filed 2020-03-12 | -$13.00K 20-F · filed 2018-03-15 | |
| 2016-12-31 | -$106.00K 20-F · filed 2019-03-11 | -$101.00K 20-F · filed 2018-03-15 | |
| 2015-12-31 | -$117.00K 20-F · filed 2018-03-15 |